Skip to content

Language: Japanese

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

By asianet

— European Commission Decision Anticipated within Approximately 60 Days — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion … Continued

Nike at 50: A Genealogy of Progress

By asianet

Local Celebration of the Never-Ending Journey of Serving Athletes #Nike50 #NikeAt50HKG #JustDoIt Nike’s mission of bringing inspiration and innovation to every athlete* is fuelled by a belief that it is “never done”. Like the athletes it serves, Nike is constantly setting new goals and new ambitions. “With every shoe, we got better. With every mistake, … Continued

FII Institute unveils new Inclusive ESG (TM) Framework and Scoring Methodology & announces strategic investment in leading green tech firm

By asianet

The Future Investment Initiative (FII) Institute hosted a London summit about ESG in Emerging Markets, involving world leaders, global CEOs, international investors, thought leaders and heads of sustainability, where: – It unveiled a new Inclusive ESG(TM)Framework and Scoring Methodology to inform and accelerate ESG investments in emerging economies; – It launched an ESG White Paper … Continued

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host international conference on complex cardiac arrhythmias

By asianet

EPLive 2022 is a two-day conference that draws the world’s top cardiac electrophysiology experts On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center will host its sixth international symposium on complex arrhythmias, EPLive 2022. EPLive is an intensive, two-day educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist … Continued

Tata Communications launches DIGO – integrated platform for converged and contextual conversations

By asianet

To transform customer engagement with intelligent Human to Everything (H2X) interactions across all customer experience (CX) platforms of digital-first businesses Tata Communications[https://www.tatacommunications.com/], a global digital ecosystem enabler, today launches DIGO[https://digo.io/], an in-network, cloud communications platform to power up customer engagement for digital-first businesses. The platform offers a full suite of device-agnostic communications tools to seamlessly … Continued

Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

By asianet

-Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patients -PFS rate at 12 months with elacestrant was 22.32% vs. 9.42% with SOC in the overall population, and 26.76% vs. 8.19% in the ESR1 mutation population -Data demonstrated elacestrant significantly reduced the risk of disease … Continued

Arasan announces its 2’nd Generation of CAN IP

By asianet

–Arasan, a leading provider of semiconductor IP for all things mobile, including automobiles announces its 2’nd generation of CAN IP Arasan announces the immediate availability of its 2’nd generation of CAN IP for the CAN 2.0 and CAN FD Specifications. The controllers have been rearchitected and upgraded to lower power consumption and area, which make … Continued